PET Tracer

DIAGNOSTIC_TEST3 trials

Sponsors

Takashi Kato, NYU Langone Health, Frederic Pouliot

Conditions

MCI,mildAD ADNeuropsychiatric Post-Acute Sequelae of SARS-CoV-2 InfectionmCRPC (Metastatic Castration-resistant Prostate Cancer)

Unknown Phase

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

Active, not recruitingNCT05615415

NYU Langone HealthNeuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection

Start: 2022-02-15End: 2026-12-31Updated: 2025-11-28

RecruitingJPRN-jRCTs031250335

Takashi KatoMCI,mildAD AD

Start: 2025-09-03Target: 80Updated: 2026-06-29

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

RecruitingNCT07302763

Frederic PouliotmCRPC (Metastatic Castration-resistant Prostate Cancer)

Start: 2025-11-04End: 2030-12-31Target: 45Updated: 2025-12-24